A Phase 4 Study to Assess Symptoms of Exocrine Pancreatic Insufficiency in Subjects with Cystic Fibrosis or Chronic Pancreatitis Treated with Creon (Pancrelipase) with an Alternate Source of Active Pharmaceutical Ingredient
Brief description of study
The goal of this study is to be able to determine the effects taking CREON for patients suffering from exocrine pancreatic insufficiency (EPI) due to Chronic pancreatitis (CP) or Cystic Fibrosis (CF). This study will last about 5 months and will involve 2-3 in person visits. Participants will be asked to provide information regarding their demographic, and medical history. As well as complete 1 blood draw, and fill out surveys related to their overall health. Participants must have a medical condition (Exocrine Pancreatic Insufficiency) being studied and/or are scheduled to have test/procedure.
Clinical Study Identifier: s21-01159
If you are registered as a volunteer, please log in to contact the study team/express interest in this study.
